Evolent Health, Inc Class A Common Stock EVH
$4.04
+2.02%
at last close
Analyst Consensus
- Consensus Rating
- Buy (10 Buy · 3 Hold · 0 Sell)
- Average Price Target
- $6.17
- Implied Upside
- +52.6%
- Price Target Range
- $3.00 – $10.00
- Analysts (12 mo)
- 13
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-08-18 | JP MorganJohn Stansel |
Maintains | Overweight | $5 → $6 |
| 2026-08-17 | TD CowenCharles Rhyee |
Maintains | Buy | $5 → $6 |
| 2026-08-12 | Truist SecuritiesJailendra Singh |
Maintains | Hold | $7 → $6 |
| 2026-08-11 | CitigroupDaniel Grosslight |
Upgrades | Neutral → Buy | $7 → $6 |
| 2026-08-10 | Canaccord GenuityRichard Close |
Maintains | Buy | $7 → $6 |
| 2026-07-28 | TD CowenCharles Rhyee |
Maintains | Buy | $8 → $5 |
| 2026-07-23 | CitigroupDaniel Grosslight |
Downgrades | Buy → Neutral | $6 → $7 |
| 2026-07-21 | Canaccord GenuityRichard Close |
Maintains | Buy | $6 → $7 |
| 2026-06-30 | Truist SecuritiesJailendra Singh |
Downgrades | Buy → Hold | $7 |
| 2026-06-12 | Truist SecuritiesJailendra Singh |
Maintains | Buy | $6 → $7 |
| 2026-05-15 | CitigroupDaniel Grosslight |
Maintains | Buy | $4 → $6 |
| 2026-05-12 | Canaccord GenuityRichard Close |
Maintains | Buy | $4 → $6 |
| 2026-05-07 | NeedhamMatthew Shea |
Maintains | Buy | $4 → $5 |
| 2026-03-02 | OppenheimerMichael Wiederhorn |
Maintains | Outperform | $12 → $6 |
| 2026-02-26 | CitigroupDaniel Grosslight |
Maintains | Buy | $6 → $4 |
| 2026-02-26 | UBSKevin Caliendo |
Maintains | Buy | $10 → $5 |
| 2026-02-26 | Truist SecuritiesJailendra Singh |
Maintains | Buy | $10 → $6 |
| 2026-02-25 | NeedhamMatthew Shea |
Maintains | Buy | $15 → $4 |
| 2026-02-25 | RBC CapitalRyan Halsted |
Maintains | Sector perform | $5 → $3 |
| 2026-02-25 | KeybancMatthew Gillmor |
Downgrades | Overweight → Sector weight | — |
| 2026-02-25 | BTIGDavid Larsen |
Maintains | Buy | $10 → $8 |
| 2026-02-02 | BTIGDavid Larsen |
Maintains | Buy | $16 → $10 |
| 2026-01-09 | CitigroupDaniel Grosslight |
Maintains | Buy | $10 → $6 |
| 2026-01-06 | CitizensConstantine Davides |
Maintains | Market outperform | $11 → $10 |
| 2025-11-21 | CitigroupDaniel Grosslight |
Maintains | Buy | $12 → $10 |
| 2025-11-17 | JP MorganAnne Samuel |
Maintains | Overweight | $13 → $7 |
| 2025-11-14 | Canaccord GenuityRichard Close |
Maintains | Buy | $16 → $9 |
| 2025-11-13 | BMO CapitalSean Dodge |
Initiates coverage on | Outperform | $7 |
| 2025-11-12 | OppenheimerMichael Wiederhorn |
Maintains | Outperform | $18 → $12 |
| 2025-11-10 | Truist SecuritiesJailendra Singh |
Maintains | Buy | $16 → $10 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $4.04
- Market Cap
- $456.76 million
- 52-Week Range
- $2.10 – $10.08
- Average Volume
- 2.28 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.